Estimation of Readmission Factors for ACS Patients Who Received Clopidogrel with Clopidogrel PPIs by Data Mining Techniques
碩士 === 國立中正大學 === 醫療資訊管理研究所 === 103 === Acute coronary syndrome (ACS) refers to any clinical manifestations of myocardial ischemia, which often caused by coronary thrombosis. For secondary prevention, clinic physicians use antiplatelet agents, such as clopidogrel, to decrease platelet aggregation th...
Main Authors: | Kuan-Chen Chen, 陳冠臻 |
---|---|
Other Authors: | I-Chiu Chang Ph.D. |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/rup9bt |
Similar Items
-
PPIs Are Not Responsible for Elevating Cardiovascular Risk in Patients on Clopidogrel—A Systematic Review and Meta-Analysis
by: Alexandra Demcsák, et al.
Published: (2018-11-01) -
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
by: Xingyang Yi, et al.
Published: (2020-04-01) -
CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01) -
The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01) -
GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA
by: K. B. Mirzaev, et al.
Published: (2015-10-01)